undamentalytics Newsletter

Glarner Terrence: insider trades

Director at NVE Corp. No open-market purchases and 17 sales not made under a pre-set plan, reported from March 9, 2010 to November 5, 2024.

What happened after Glarner Terrence’s sales?

After their sales, the shares moved −10.1% against the index over 12 months on average (a negative figure means selling was the right call); 65% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Glarner Terrence: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 17 −2.4% −2.8% 65% 9 −0.26 0.80 No reliable evidence
Sales, 12 months after the report 17 −10.1% −10.0% 65% 9 −1.31 0.23 No reliable evidence
Sales, 12 months after the trade 17 −10.3% −14.4% 59% 9 −1.35 0.21 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
NVE Corp NVEC —017March 9, 2010November 5, 2024

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
November 5, 2024November 5, 2024 NVEC Sale $36,730 −14.6%−32.2%−25.3%
August 15, 2024August 15, 2024 NVEC Sale $27,076 −11.9%−34.7%−33.3%
June 11, 2024June 11, 2024 NVEC Sale $15,150 −7.0%−18.0%−19.1%
January 26, 2024January 25, 2024 NVEC Sale $21,634 +0.6%−29.6%−34.3%
March 6, 2023March 3, 2023 NVEC Sale $78,160 +22.4%−10.0%−15.5%
July 24, 2019July 23, 2019 NVEC Sale $69,240 −2.8%−24.9%−14.4%
August 16, 2018August 15, 2018 NVEC Sale $230,000 −23.8%−42.6%−42.2%
November 28, 2017November 28, 2017 NVEC Sale $85,890 −12.3%+11.0%+6.9%
May 22, 2017May 22, 2017 NVEC Sale $79,040 −9.4%+22.0%+18.3%
February 27, 2017February 27, 2017 NVEC Sale $79,570 +0.4%−23.9%−25.0%
December 2, 2016December 2, 2016 NVEC Sale $66,120 +22.4%+2.7%+4.1%
August 11, 2016August 11, 2016 NVEC Sale $57,860 +5.1%+21.4%+17.8%
November 5, 2013November 4, 2013 NVEC Sale $53,390 −0.1%+24.4%+22.6%
August 24, 2011August 23, 2011 NVEC Sale $59,510 −13.8%−36.9%−36.7%
February 2, 2011February 1, 2011 NVEC Sale $233,400 −7.5%−6.0%−11.5%
November 3, 2010November 1, 2010 NVEC Sale $47,570 +11.5%+6.9%+9.2%
March 9, 2010March 5, 2010 NVEC Sale $47,800 0.0%−1.2%+3.4%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Glarner Terrence traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.